SEC Form 4 · accession 0001209191-17-053165
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ryan Lynch
Officer — PFO, PAO
Period of report
Sep 14, 2017
Accepted (ET)
Sep 18, 2017 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 14, 2017 | M | 3,500 | $9.46 | A | 9,500 | D | |
| Common Stock | Sep 14, 2017 | S | 3,500 | $14.51 | D | 6,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $9.46 | Sep 14, 2017 | M | 3,500 | D | — | Jun 11, 2024 | Common Stock | 3,500 | 3,200 | D |
Explanation of responses
- F1Twenty five percent (25%) of the shares subject to this option vested on June 12, 2015, and the option vested and will continue to vest in equal quarterly installments thereafter, until June 12, 2018, at which time this option will be fully vested.